Sara Smith | Director of Investor Relations |
Dave Ricks | Chairman and CEO |
Josh Smiley | Chief Financial Officer |
Dan Skovronsky | President of Lilly Research Laboratories |
Anne White | President of Lilly Oncology |
Mike Mason | President of Lilly Diabetes |
Jacob Van Naarden | Chief Operating Officer Loxo Oncology at Lilly |
Ilya Yuffa | President of Lilly Bio-Medicines |
Chris Schott | JPMorgan |
Tim Anderson | Wolfe Research |
Andrew Baum | Citi |
Terence Flynn | Goldman Sachs |
Carter Gould | Barclays |
Seamus Fernandez | Guggenheim |
Louise Chen | Cantor |
Geoff Meacham | Bank of America Merrill Lynch |
Vamil Divan | Mizuho Securities |
Steve Scala | Cowen |
Ronny Gal | Bernstein |
David Risinger | Morgan Stanley |
Greg Gilbert | Truist Security |
Umer Raffat | Evercore ISI |
Ladies and gentlemen, thank you for standing by and welcome to the Lilly 2021 Guidance Call. At this time, all lines are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] And as a reminder, today’s conference call is being recorded. I would now like to turn the conference over to Sara Smith.